Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease.


Biomarkers complement clinical assessment, electrocardiogram and cardiac imaging in the diagnosis, risk stratification, triage and management of patients with suspected acute cardiovascular diseases. While there is broad consensus that cardiac troponin is the preferred biomarker in clinical practice for the detection of cardiomyocyte damage, the role of… (More)
DOI: 10.1586/14737159.2015.1010519


5 Figures and Tables